Brazil Bans Nationwide Sale of Electronic Smoking Devices (DEF)

Sep.06.2022
Brazil Bans Nationwide Sale of Electronic Smoking Devices (DEF)
Brazil bans nationwide sale of electronic cigarettes to protect consumer health. 33 companies must stop sales, supply, and distribution.

Brazil has banned the sale of electronic smoking devices (DEF) nationwide. The Ministry of Justice made a decision through the National Consumer Secretariat (Senacon), which determined that 33 companies must temporarily suspend the sale, supply, and distribution of the product.


The measure was announced on the final day of January in the Official Gazette (DOU), with companies given 48 hours to comply. Failure to do so would result in a daily fine of 5,000 reais.


In Brazil, electronic cigarettes are easily sold, despite a ban on marketing. This poses a threat to consumers' health due to the sale of illegal products that are deemed "legal" at the time of sale. The electronic cigarettes sold in the market do not comply with safety certifications from the regulatory authorities as stated in measures released by DOU.


The document also discusses the young people's consumption of the product, as they still believe that e-cigarettes do not harm their health. For the Department of Justice, the lack of transparency and regulation in the product renders it illegal.


Since 2009, Brazil has prohibited the use of electronic cigarettes. Despite enforcement agencies cracking down and confiscating products, electronic cigarettes remain popular.


According to data released by Brazil's National Health Surveillance Agency (Anvisa), 20% of young people aged 18 to 24 have tried electronic cigarettes.


It's important to understand that despite claims from manufacturers that the product is less harmful to one's health, electronic cigarettes rely on liquid nicotine mixed with oil and solvents. When inhaling this mixture, especially with continued use, an individual may experience respiratory symptoms and develop lung, heart, and cancer diseases.


Statement:


This article is compiled from third-party information and is intended for industry professionals for educational sharing.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content of the article. The translation of this article is intended for industry communication and research purposes only.


Due to limitations in our translation ability, the compiled article may not fully reflect the exact meaning of the original. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The compilation of information is subject to copyright owned by the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
According to Beritasatu, Commission III of the Indonesian House of Representatives is reviewing the Draft Law on Narcotics and Psychotropics and considering including a proposal from the National Narcotics Agency (BNN) to ban vapes.
Apr.10 by 2FIRSTS.ai
Imperial Brands to Close Langenhagen Cigarette Factory by 2027
Imperial Brands to Close Langenhagen Cigarette Factory by 2027
Imperial Brands said it will gradually close the Reemtsma factory in Langenhagen near Hanover by 2027 after efforts to find a buyer failed to produce a sustainable agreement. The factory has produced cigarettes since 1971 and currently affects around 600 employees. The company said it had examined all realistic options over recent months but did not receive a binding offer from a potential buyer.
Mar.27 by 2FIRSTS.ai
Manchester’s Cheetham Hill Hosts 54 Vape Shops Across Two Streets
Manchester’s Cheetham Hill Hosts 54 Vape Shops Across Two Streets
Cheetham Hill in Greater Manchester has become one of the UK’s most concentrated vape retail clusters, with 54 e-cigarette shops operating along two adjacent streets following a police crackdown on counterfeit goods in the area.
Feb.21
Louisiana lawmaker pushes bill to ban vape product sales within 300 feet of schools
Louisiana lawmaker pushes bill to ban vape product sales within 300 feet of schools
A Louisiana lawmaker has introduced HB 302, which would prohibit businesses from selling vapor products within 300 feet of schools. The bill would measure the distance by a person walking on the sidewalk from the nearest point on school property to the nearest point of the business. It would also give the commissioner authority to modify how the distance is calculated, while maintaining the 300-foot limit.
Feb.26 by 2FIRSTS.ai
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
2Firsts Interview with Glas |Why a California ENDS Company Believes Its Age-gated Flavored Vape Could Be Next in Line for FDA Authorization
As the FDA advances efforts to streamline its PMTA review process, including support for small businesses, expectations are rising that additional product authorizations may follow. Age-verification technology is emerging as a key consideration in future approvals.In this interview, California-based Glas discusses its G2 platform, integrating smartphone-based identity verification, proximity controls and anti-counterfeit systems, and outlines its positioning under the FDA’s PMTA framework.
Mar.02